Please: Login/Register

The Latest Edition of "Eyes on malaria" magazine will be out very soon!! | CALL FOR ARTICLES: AMMREN is inviting journalists / writers / scientists interested in reporting on malaria to send articles for publication in its international magazine “Eyes on Malaria” and for posting on its website. Please contact the AMMREN Secretariat for more details click here. Enjoy your stay!. Volunteers and interns urgently needed to work with an NGO working in the area of malaria and health. Apply through - ammren1@gmail.com / ammren1@yahoo.com. Journalists interested in reporting on and writing articles on health issues should please reply through this email: ammren1@gmail.com

ANNOUNCEMENTS:::

TIPS ON MALARIA

  • HOW CAN MOSQUITOES BE CONTROLLED?

    Mosquitoes around the home can be reduced significantly by minimizing the amount of standing water available for mosquito breeding. Residents are urged to reduce standing water around the home in a variety of ways.

  • HOW CAN I PROTECT MYSELF FROM MOSQUITO-BORN DISEASES?

    The best way is to avoid being bitten by mosquitoes.This can be accomplished using personal protecting  while outdoors when mosquitoes are present. Treated bed nets should be used sleeping. Mosquito repellent should be used when outdoor.

  • WHO ARE AT RISK?


    Nearly half of the world’s population is at risk of getting malaria. Pregnant women are particularly at risk of malaria. Children under 5 years are at high risk of malaria.
     

MAGAZINE EDITIONS

  • First Edition

  • Second Edition

  • Third Edition

  • Fourth Edition

  • Fifth Edition

  • Sixth Edition

  • Seventh Edition

  • Eighth Edition

  • Ninth Edition

  • Special Edition

  • INESS Edition

  • Tenth Edition

  • INDEPTH Edition

  • Eleventh Edition

  • Twelfth Edition

  • Special Edition

  • Special Edition

  • Volume 1

  • Volume 2

Special Editon Editorial

This Special Edition of the Eyes on Malaria Magazine looks at the end-of-project activities carried out on the INDEPTH Effectiveness and Safety Studies (INESS) platform in Ghana, Tanzania, Burkina Faso and Mozambique.

The platform was created over five years ago as the largest phase 4 structure on the African continent to evaluate anti-malarials in relation to their efficacy and effectiveness in
treating patients in typical health systems in Africa. The project is also to enhance the capacity of Africans to carry out phase 4 studies, locally.

The project, which focuses on providing objective data to inform policy at the national and global level, is to help strengthen Health and Demographic Surveillance Systems (HDSS) in the four countries to serve as a platform to monitor the safety and effectiveness of new medical products and vaccines so they do not lose their effectiveness through a host of health-system related factors.

Quite recently, follow-up studies were conducted on the INESS platform to test the safety of the branded anti-malaria drug, Eurar tesim, (dihydroar temisinin-piperaquine).

The researchers who worked on the platform believe they now have enough data and the capacity to run phase 4 studies.

Thus, the INESS platform is ready to assess any post-registered drug, vaccine or product due to the community of researchers and logistics created and now available to help in policy decisions based on research.

What is left is for researchers and policy-makers to work together and make use of data generated from these studies.

The INESS project should not just be used to gather information but it must drive policy to bring about evidence-based solutions and development within the health systems in Africa.

EDITORIAL TEAM
Charity Binka
MANAGING EDITOR

Eunice Menka
ASSISTANT EDITOR

COUNTRY CO-ORDINATORS
James Addy
Ghana

Rebecca Chimjeka
Malawi

Isaiah Esipisu
Kenya

Momodou Faal
Gambia

Mbarwa Kivuyo
Tanzania

Idrissa Ndiaye
Senegal

Editions: 
Special Edition New